Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.61 USD | -0.40% | +31.01% | +113.79% |
Financials (USD)
Sales 2024 * | 44.62M | Sales 2025 * | 131M | Capitalization | 2.7B |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -346M | EV / Sales 2024 * | 58.9 x |
Net cash position 2024 * | 76.75M | Net cash position 2025 * | 15.43M | EV / Sales 2025 * | 20.5 x |
P/E ratio 2024 * |
-68.9
x | P/E ratio 2025 * |
-8.44
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.65% |
Latest transcript on Agios Pharmaceuticals, Inc.
1 day | -0.40% | ||
1 week | +31.01% | ||
Current month | +31.01% | ||
1 month | +46.67% | ||
3 months | +52.16% | ||
6 months | +115.92% | ||
Current year | +113.79% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.52% | 1 M€ | +0.84% | - | |
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 415 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 47.61 | -0.40% | 701,963 |
24-06-06 | 47.8 | -2.11% | 961,606 |
24-06-05 | 48.83 | +3.13% | 1,230,379 |
24-06-04 | 47.35 | +8.03% | 1,806,028 |
24-06-03 | 43.83 | +20.61% | 2,025,960 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.79% | 2.7B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- AGIO Stock